A Study on Evaluation of Renal Drug Dosing Practices, Stages, Treatment Profile and Outcomes in Kidney Disease Patients in a Tertiary Care Hospital

Abstract

Introduction: Kidney damage refers to pathologic abnormalities suggested by imaging studies or renal biopsy, abnormalities in urinary sediment, or increased urinary albumin excretion rates. The true incidence and prevalence of CKD are challenging to determine due to the asymptomatic nature of early to moderate stages. Methodology: The prospective observational study was carried out for a period of 6 months. The study was conducted in Nephrology department in a tertiary care hospital. A written and informed consent was obtained from the recruited patients. A Total of 200 patients were enrolled in the study. Aim: The study aimed to assess the renal dosing practices, stages, treatment profile and outcomes in kidney disease patients in a tertiary care hospital. Results & Discussion: In our study 36-45 years age patients were 59(29.5%) as compared to other ages. Stages of renal failure includes 5 stage patients were more 66(33%) as compared to other renal failure stages. Clinical manifestations of renal failure Patients Dysuria patients were more 63 (31.5%), as compared to other clinical symptoms. Drug prescribing pattern for renal failure management includes ACE inhibitors prescribed drugs patients were more 56 (28%) as compared to ARB prescribed drugs patients were 52 (26%), Calcitriol prescribed drugs patients were 33 (16.5%), Vitamin D prescribed drugs patients were 25 (12.5%), Atorvastatin prescribed drugs patients were 34 (17%). Conclusion: To combat the rising burden of CKD, comprehensive strategies must be implemented, including early detection, management of underlying conditions, lifestyle modifications, and public health interventions to address environmental and genetic factors at the clinical level.